GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genxone SA (WAR:GX1) » Definitions » Revenue

Genxone (WAR:GX1) Revenue : zł2.01 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Genxone Revenue?

Genxone's revenue for the three months ended in Mar. 2024 was zł0.32 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was zł2.01 Mil. Genxone's Revenue per Share for the three months ended in Mar. 2024 was zł0.10. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was zł0.61.

Warning Sign:

Genxone SA revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Genxone was -49.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -51.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 140.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 6 years, Genxone's highest 3-Year average Revenue per Share Growth Rate was 645.30% per year. The lowest was -51.10% per year. And the median was 272.80% per year.


Genxone Revenue Historical Data

The historical data trend for Genxone's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genxone Revenue Chart

Genxone Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial 0.21 20.47 23.20 10.59 2.40

Genxone Quarterly Data
Mar19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.77 0.37 0.56 0.32

Competitive Comparison of Genxone's Revenue

For the Biotechnology subindustry, Genxone's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genxone's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genxone's Revenue distribution charts can be found below:

* The bar in red indicates where Genxone's Revenue falls into.



Genxone Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł2.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genxone  (WAR:GX1) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Genxone Revenue Related Terms

Thank you for viewing the detailed overview of Genxone's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Genxone (WAR:GX1) Business Description

Traded in Other Exchanges
N/A
Address
ul. Kobaltowa 6, Zlotniki, Suchy Las, POL, 62-002
Genxone SA is a biotechnology company that applies nanopore sequencing technology (third-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. It specializes in developing new products and solutions based on the latest technologies of nucleic acid sequencing. The company's services include NANOPORE SEQUENCING that includes Whole Genome Sequencing, Bespoke Analysis, Metagenome Sequencing, Bioinformatic Analysis, 16S and/or ITS Gene Sequencing, and RNA Sequencing; and DIAGNOSTIC TESTS that includes Gastrointestinal Infections Panel, Respiratory Infections Panel, Urogenital Infection Panel, and Nervous System Infection Panel.

Genxone (WAR:GX1) Headlines

No Headlines